Regulation of cell proliferation and cell death by peroxisome proliferators

Microscopy Research and Technique

Volumn 61, Issue 2, 2003, Pages 179-184

  Cattley, Russell C ^a  

^a AMGEN INC   (United States)

Author keywords

Cell death; Cell proliferation; Peroxisome proliferators

Indexed keywords

CELL PROLIFERATION; MAMMALS;

HEPATOCYTES; LIVER TUMORS; NUCLEAR RECEPTORS; PEROXISOME PROLIFERATORS; SIGNALLING PATHWAYS; TO EFFECT;

CELL DEATH;

CELL NUCLEUS RECEPTOR; CLOFIBRATE; NAFENOPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL CELL; ANIMAL TISSUE; CELL DEATH; CELL PROLIFERATION; CONFERENCE PAPER; LIVER CELL; LIVER TUMOR; LIVER WEIGHT; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RODENT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TUMOR CELL;

RODENTIA;

EID: 0038219559     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10327     Document Type: Conference Paper

References (51)

1. Anderson SP, Dunn CS, Cattley RC, Corton JC. 2001. Hepatocellular proliferation in response to a peroxisome proliferator does not require tnfα, signaling. Carcinogenesis 22:1843-1851.
2. Barrass NC, Price RJ, Lake BG, Orton TC. 1993. Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylelofenapate and clofibric acid in rat liver. Carcinogenesis 14:1451-1456.
3. Bojes HK, Thurman RG. 1996. Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res 56:1-4.
4. Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, Thurman RG. 1997. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis 18:669-674.
5. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. 1990. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11:847-853.
6. Cattley RC, DeLuca J, Elcombe C, Fenner-Crisp P, Lake BG, Marsman DS, Pastoor TA, Popp JA, Robinson DE, Schwetz B, Tugwood J, Wahli W. 1998. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 27:47-60.
7. Choudhury AI, Chahal S, Bell AR, Tomlinson SR, Roberts RA, Salter AM, Bell DR. 2000. Species differences in peroxisome proliferation; mechanisms and relevance. Mutat Res 448:201-212.
8. Christensen JG, Gonzales AJ, Cattley RC, Goldsworthy TL. 1998. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ 9:815-825.
9. Coni P, Simbula G, de Prati AC, Menegazzi M, Suzuki H, Sarma DS, Ledda-Columbano GM, Columbano A. 1993. Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration. Hepatology 17:1109-1116.
10. Diehl AM. 2000. Cytokine regulation of liver injury and repair. Immunol Rev 174:160-171.
11. Escher P, Wahli W. 2000. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448:121-138.
12. Fausto N. 2000. Liver regeneration. J Hepatol 32(Suppl 1):19-31.
13. Fox TR, Best LL, Goldsworthy SM, Mills JJ, Goldsworthy TL. 1993. Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Cancer Res 53:2265-2271.
14. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. 1995. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21:1465-1468.
15. Grasl-Kraupp B, Ruttkay-Nedecky B, Mullauer L, Taper H, Huber W, Bursch W, Schulte-Hermann R. 1997. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25:906-912.
16. Grasl-Kraupp B, Rossmanith W, Ruttkay-Nedecky B, Mullauer L, Kammerer B, Bursch W, Schulte-Hermann R. 1998. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia. Hepatology 28:717-726.
17. Greaves P, Irisarri E, Monro AM. 1986. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility. J Natl Cancer Inst 76:475-484.
18. Hasmall SC, James NH, Macdonald N, Gonzalez FJ, Peters JM, Roberts RA. 2000. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. Mutat Res 448:193-200.
19. Hofstra AH, King LM, Walker RM. 1997. Early effects of CI-924 on hepatic peroxisome proliferation, microsomal enzyme induction, PCNA, and apoptosis in B6C3F1 mice and Wistar rats. Arch Toxicol 71:250-257.
20. Holden PR, Hasmall SC, James NH, West DR, Brindle RD, Gonzalez FJ, Peters JM, Roberts RA. 2000. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin. Cell Mol Biol (Noisy-le-grand) 46:29-39.
21. James NH, Soames AR, Roberts RA. 1998. Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse carcinogen diethylhexylphthalate (DEHP) and the mouse hepatocarcinogen 1,2-dichlorobenzene (DCB). Arch Toxicol 72:784-790.
22. Jirtle RL, Carr BI, Scott CD. 1991. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration. J Biol Chem 266:22444-22450.
23. Kolaja KL, Stevenson DE, Johnson JT, Walborg Jr EF, Klaunig JE. 1996. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam Appl Toxicol 29:219-228.
24. Kurata Y, Kidachi F, Yokoyama M, Toyota N, Tsuchitani M, Katoh M. 1998. Subchronic, toxicity of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol Sci 42:49-56.
25. Lake BG, Rumsby PC, Price RJ, Cunninghame ME. 2000. Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-betal gene expression in the rat, Syrian hamster and guinea pig. Mutat Res 448:213-225.
26. Lake BG, Evans JG, Gray TJ, Korosi SA, North CJ. 1989. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset. Toxicol Appl Pharmacol 99:148-160.
27. Lawrence JW, Wollenberg GK, DeLuca JG. 2001. Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation. Carcinogenesis 22:381-386.
28. Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C, Shinozuka H, Bluethmann H, Poli V, Ciliberto G, Columbano A. 1998. In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 17:1039-1044.
29. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022.
30. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
31. Makowska JM, Gibson GG, Bonner FW. 1992. Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation. J Biochem Toxicol 7:183-191.
32. Marsman DS, Cattley RC, Conway JG, Popp JA. 1988. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (Wy-14,643) in rats. Cancer Res 48:6739-6744.
33. Marsman DS, Goldsworthy TL, Popp JA. 1992. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis 13:1011-1017.
34. Menegazzi M, Carcereri-De Prati A, Suzuki H, Shinozuka H, Pibiri M, Piga R, Columbano A, Ledda-Columbano GM. 1997. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha. Hepatology 25:585-592.
35. Miller RT, Glover SE, Stewart WS, Corton JC, Popp JA, Cattley RC. 1996. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643. Carcinogenesis 17:1337-1341.
36. Miller RT, Anderson SP, Corton JC, Cattley RC. 2000. Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas. Carcinogenesis 21:647-652.
37. Ohmura T, Ledda-Columbano GM, Piga R, Columbano A, Glemba J, Katyal SL, Locker J, Shinozuka H. 1996. Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol 148:815-824.
38. Palmer CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. 1998. Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 53:14-22.
39. Peters JM, Cattley RC, Gonzalez FJ. 1997. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18:2029-2033.
40. Peters JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG. 2000. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcino- genesis. Carcinogenesis 21:823-826.
41. Price RJ, Evans JG, Lake BG. 1992. Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster. Food Chem Toxicol 30:937-944.
42. Reddy JK, Lalwani ND. 1983. Carcinogenesis by hepatic peroxisome proliferators: industrial plasticizers to humans. Crit Rev Toxicol 12:1-58.
43. Roberts RA. 1999. Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences. Arch Toxicol 73:413-418.
44. Roberts RA, Soames AR, Gill JH, James NH, Wheeldon EB. 1995. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 16:1693-1698.
45. Rose ML, Germolec DR, Schoonhoven R, Thurman RG. 1997. Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18:1453-1456.
46. Rusyn I, Tsukamoto H, Thurman RG. 1998. WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis 19:1217-1222.
47. Rusyn I, Yamashina S, Segal BH, Schoonhoven R, Holland SM, Cattley RC, Swenberg JA, Thurman RG. 2000. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res 60:4798-4803.
48. Tanaka K, Smith PF, Stromberg PC, Eydelloth RS, Herold EG, Grossman SJ, Frank JD, Hertzog PR, Soper KA, Keenan KP. 1992. Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol Appl Pharmacol 116:71-77.
49. Taub R, Greenbaum LE, Peng Y. 1999. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 19:117-127.
50. Ward JM, Peters JM, Perella CM, Gonzalez FJ. 1998. Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)-phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol Pathol 26:240-246.
51. West DA, James NH, Cosulich SC, Holden PR, Brindle R, Rolfe M, Roberts RA. 1999. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin. Hepatology 30:1417-1424.